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Oxidative stress, a consequence of an imbalance between the 
formation and inactivation of reactive oxygen species, may be 
involved in the pathogenesis of many diseases including cancer. 
To evaluate the magnitude of oxidative stress, a study on the 
plasma  levels  of  superoxide  dismutase,  total  thiols,  ascorbic 
acid and malondialdehyde (MDA) has been done in head and 
neck squamous cell carcinoma patients before the start of any 
oncological treatment and compared with healthy controls. The 
specific  activity  of  superoxide  dismutase  in  cancer  patients  is 
decreased significantly when compared to the control (p < 0.05). 
The total thiol and ascorbic acid levels are significantly reduced 
(p < 0.005) whereas MDA levels are significantly increased in 
the patients (p < 0.00005). Our findings show that the oxidative 
stress is elevated in cancer patients as evidenced by elevated levels 
of lipid peroxidation products and depletion of enzymatic and 
non-enzymatic antioxidants.
Introduction
Carcinogenesis is a complex multisequential process leading a 
cell from a healthy to a precancerous state and finally to an early 
cancerous stage. Three distinct stages of carcinogenesis have been 
defined and these include initiation, promotion and progression.1 
It has been proposed that reactive oxygen species are associated 
with the different stages of carcinogenesis through structural DNA 
damage, interaction with oncogenes, tumor suppressor genes or 
immunological mechanisms.2
A substantial body of evidence has been produced that links 
the production of reactive oxygen species (ROS) and subsequently 
oxidative stress and damage to the pathogenesis of age related and 
chronic diseases and cancer.3-6 Oxidative stress has been defined 
as an imbalance between pro-oxidants and antioxidants in favor 
of the former, resulting in an overall increase in cellular levels of 
reactive  oxygen  species.7  Reactive  oxygen  species  such  as  O2
.-, 
H2O2 and OH., are generated inevitably as a part of normal cell 
metabolism including oxidative phosphorylation, P450 metabo-
lism,  peroxisomes  and  inflammatory  cell  activation.  ROS  can 
interact with cellular macromolecules such as DNA, proteins and 
lipids and interfere with vital cellular functions. ROS can cause 
DNA base alterations, strand breaks, damage to tumor suppressor 
genes and enhance expression of proto-oncogenes.8 These oxida-
tive modifications could result in the transformation of normal 
cells into malignant cells.3 The prime target of peroxidation by 
ROS are the polyunsaturated fatty acids (PUFA) in the membrane 
lipids leading to the formation of lipid peroxides such as malondi-
aldehyde (MDA).9 MDA itself, owing to its high cytotoxicity and 
inhibitory action on protective enzymes, is suggested to act as a 
tumor promoter and a co-carcinogenic agent.10
Under  normal  physiological  conditions,  cells  are  capable  of 
counterbalancing the noxious effects of reactive oxygen species with 
antioxidant defense system which consists of free radical scavengers 
including superoxide dismutase, catalase, glutathione peroxidase 
and glutathione reductase and non enzymatic antioxidants such 
as thiols and various other substances taken along with food such 
as vitamin E, vitamin C, β-carotene and flavanoids. Antioxidant 
defense systems work cooperatively to alleviate the oxidative stress 
caused by enhanced production of the free radicals. Any change in 
one of these systems may break this equilibrium and cause cellular 
damage and ultimately malignant transformation.
Tobacco,  an  exogenous  source  of  reactive  oxygen  species,  is 
believed to play a significant role in mutagenesis and carcinogen-
esis. Tobacco has been recognized as a major etiological factor for 
the head and neck cancer.11 Alkaline saliva generated by chewing 
betel quid also plays an important role in ROS mediated DNA 
damage in head and neck cancer patients.12 The head and neck 
cancer refers to a group of biologically similar cancers originating 
from the upper aerodigestive tract including the lip, oral cavity, 
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nasal cavity, para-nasal sinuses, pharynx and larynx. Most head and 
neck cancers are squamous cell carcinomas, originating from the 
mucosal lining of these regions.
The aim of this study has been to evaluate the extent of oxida-
tive  stress  in  head  and  neck  squamous  cell  carcinoma  patients 
before  the  start  of  any  oncological  treatment  by  analyzing  the 
plasma  levels  of  the  free  radical  scavenging  enzyme  superoxide 
dismutase  and  antioxidants  total  thiols  and  ascorbic  acid.  Free 
radical  mediated  damage  was  also  assessed  simultaneously  by 
measuring the plasma levels of MDA.
Results
The inclusion criteria for patients comprised of the following 
parameters: the age group between 20–70 years and Karnofsky 
Performance  Score  (KPS)  >70.  Subjects  (both  control  and  the 
patients)  with  other  co-morbidity  and  diseases  were  excluded 
from the study. The patient group comprised of 17 male patients 
(mean age 52.71 ± 14.40). Tumor and node size was noted and 
patients were staged according to AJCC-2002, TNM classifica-
tion. Personal profiles and clinical parameters of the patients are 
presented in Table 1. Ten out of the total 17 patients had their 
cancer  in  third  stage  while  seven  patients  had  their  cancer  in 
stage IV. Eleven patients had well differentiated cancers while five 
possessed moderately differentiated tumors. Only one patient had 
poorly differentiated cancer. Eight of the total patients had their 
primary  tumor  located  in  oral  cavity  while  seven  had  in  their 
pharyngeal region (oropharynx 3, hypopharynx 2 and nasopharynx 
2). Two patients had laryngeal carcinoma. Ten patients were heavy 
smokers while five patients were betel chewers. Twelve age and sex 
matched healthy individuals from the same Indian socio-economic 
background as of the patients served as control. The controls were 
not habituated to tobacco chewing and smoking.
Results  are  expressed  as  mean  ±  SD.  Superoxide  dismutase 
activity  and  levels  of  total  thiols,  ascorbic  acid  and  MDA  are 
presented in Table 2 and the individual observations are presented 
in Figures 1–4. The specific activity of superoxide dismutase in 
head  and  neck  squamous  cell  carcinoma  patients  is  decreased 
significantly when compared to the control (p < 0.05). Also, the 
levels  of  non-enzymatic  antioxidants,  total  thiols  and  ascorbic 
acid are significantly reduced in cancer patients (p < 0.005) when 
compared to healthy persons. The extent of lipid peroxidation as 
evidenced by the levels of MDA is significantly increased in the 
patients (p < 0.00005) compared to control.
Discussion
Cancer  is  a  heterogeneous  disorder  with  multiple  etiologies 
including somatic and germ line mutations, cellular homeostatic 
disturbances  and  environmental  triggers.  Certain  etiologies  are 
characteristic of head and neck cancer and include agents such as 
Epstein-Barr virus, the use of tobacco and consumption of alcohol. 
ROS  may  be  critically  involved  in  the  causation  of  malignant 
diseases  through  their  possible  impact  on  proto-oncogenes  and 
tumor suppressor genes. ROS may also affect the balance between 
apoptosis  and  cellular  proliferation.  If  apoptotic  mechanisms 
are  overwhelmed,  uncontrolled  cellular  formation  may  follow, 
potentially leading to tumor formation.13 ROS are also formed 
in response to tumor promoters and that cellular consequence of 
their actions may play a role in the process of tumor promotion.6 
ROS cause DNA damage, activate procarcinogens, initiate lipid 
peroxidation, inactivate enzyme systems and alter the cellular anti-
oxidants defense system.14
High  levels  of  oxidative  stress  results  in  peroxidation  of 
membrane lipids with the generation of peroxides that can decom-
pose  in  to  multiple  mutagenic  carbonyl  products  such  as  lipid 
hydroperoxides  and  malondialdehyde.  MDA  can  interact  with 
cellular  DNA  and  cause  formation  of  DNA-MDA  adducts.15 
These adducts appear to be promutagenic as they induce muta-
tion in oncogenes and tumor suppressor genes in many human 
cancers and are also correlated with altered cell cycle control and 
gene expression in cultured cells.16 The plasma MDA levels reflect 
the  extent  of  lipid  peroxidation  hence  serve  as  the  marker  for 
free radical mediated damage. In the present study, we observed 
increased  plasma  levels  of  MDA  in  head  and  neck  squamous 
cell carcinoma patients, which could be attributed to increased 
formation or inadequate clearance of free radicals by cellular anti-
oxidants.
Cellular  free  radical  scavenging  enzymes  and  antioxidants 
protect cells against toxic oxygen derived radicals. Free radical scav-
enging enzymes such as superoxide dismutase and catalase provide 
the first line of defense against free radicals. These enzymes react 
directly with oxygen free radicals to yield non-radical products. 
In our study, SOD activity was lowered in cancer patients when 
compared  to  healthy  controls.  The  decreased  activity  of  SOD 
has also been reported in other malignancies.17-19 SOD metabo-
lizes free radicals and dismutates superoxide anion to H2O2 and 
protects the cell against superoxide mediated lipid peroxidation. 
Catalase acts on H2O2 by decomposing it, thereby neutralizing its 
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Table 1    Personal profile and clinical parameters of the 
patients
No. of Patients  17
Stage:
II  0
III  10
IV  7
Differentiation:
Poorly differentiated  1
Moderately differentiated  5
Well differentiated  11
Location:
Oral cavity  8
Oropharynx  3
Hypopharynx  2
Nasopharynx  2
Larynx  2
Smokers/Nonsmokers  10/7
Betel chewers/non chewers  5/12Antioxidants status and MDA levels in head and neck cancer
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  antioxidants  when  plasma  is  exposed  to 
oxygen  free  radicals,  thus  sparing  other 
antioxidants. Significantly lowered ascorbic 
acid  levels  in  the  patients  compared  to 
healthy  individuals  may  be  linked  to 
increased oxidative stress. A strong syner-
gism  exists  between  thiols  and  ascorbic 
acid  since  regeneration  of  ascorbic  acid 
requires  thiols;  diminished  plasma  thiol 
levels  might  be  responsible  for  the  low 
levels of ascorbic acid.
To  summarize,  our  results  suggest 
that there is increased oxidative stress as 
highlighted by the elevated plasma MDA 
levels and depletion in antioxidant defense 
system.
The low levels of antioxidants in head 
and neck squamous cell carcinoma patients 
could be a result of this increased oxidative 
stress, or it could be that low values aggra-
vated the free radical damage and increase 
the chance of developing cancer, remains 
to be elucidated by further research.
Materials and Methods
All  the  chemicals  employed  in  the  study  were  of  analytical 
grade  of  Qualigens  or  equivalent.  All  the  biochemicals  used, 
were from Sigma Chemical Co., St. Louis, MO. The study was 
conducted in biopsy proven head and neck squamous cell carci-
noma  patients  registered  in  the  Department  of  Radiotherapy, 
CSM Medical University, Lucknow. The study was approved by 
the Departmental Ethical Committee. Informed consent was taken 
from all the subjects enrolled in the study.
Sample  from  all  the  subjects  was  collected  in  the  morning 
between 10–11 A.M. Taking aseptic precautions, venous blood 
(3.5 ml) was withdrawn and transferred into the polypropylene 
tubes containing 0.5 ml 3.8% sodium citrate; pH 7.2. The tubes 
were gently rotated to mix the contents and centrifuged at 2,000 xg 
for 20 min at 4°C to separate plasma. All the analyses were carried 
out on the plasma.
Assay  of  superoxide  dismutase.  Superoxide  dismutase  was 
assayed  by  the  method  described  by  Misra  and  Fridovich.25   
toxicity, but there is little or no catalase activity in plasma.20 H2O2 
is, therefore, not detoxified and accumulates to high levels and 
causes inhibition of SOD activity.21,22 Reduction of SOD activity 
may also be due to increased endogenous production of ROS as 
evidenced by elevated MDA levels.
Plasma thiol groups are contributed mainly by proteins and 
a smaller part from free-SH group containing substances, such 
as  glutathione  and  certain  other  coenzymes  which  are  critical 
endogenous  antioxidants  that  act  concurrently  in  scavenging 
and/or reducing free radicals. The plasma thiol groups break the 
peroxidative chain and allow the repair of oxidatively damaged 
molecules.23 A significant depletion of plasma thiols observed in 
our study reflects enhanced pro-oxidant milieu of the cells and 
correlates with the increased lipid peroxides in the circulation of 
cancer patients.
Ascorbic acid is an important extracellular antioxidant that is 
capable of completely inhibiting oxidative modification of lipids 
by  aqueous  peroxyl  radicals.24  It  disappears  faster  than  other 
Table 2    Plasma levels of superoxide dismutase, total thiols, ascorbic acid and MDA in the patients and healthy 
persons
  Superoxide dismutase  T-thiols  Ascorbic acid  Malondialdehyde 
  (activity/mg protein)  (µmoles/ml)  (mg/dl)  (nmoles/ml)
Healthy  2.71 ± 0.71  231.65 ± 38.02  0.43 ± 0.10  1.16 ± 0.48 
(n = 12)
Patients  2.11 ± 0.47  163.22 ± 50.18  0.27 ± 0.08  2.74 ± 1.05 
(n = 17)
p-value  p < 0.05  p < 0.0005  p < 0.0005  p < 0.00005
The data are the mean ± SD. p > 0.05 not significant; p < 0.05 significant; p < 0.005 highly significant.
Figure 1. Activity of superoxide dismutase in plasma of healthy subjects and patients.www.landesbioscience.com Oxidative Medicine and Cellular Longevity 71
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oxidation of ascorbic acid to dehydroascorbic acid, which reacts 
with  2,4  dinitro  phenyl  hydrazine  to  form  a  colored  complex 
with absorption maximum at 520 nm. L-ascorbic acid was used 
as reference.
Statistical  analyses  were  carried  out  by  student’s  t-test  using 
Sigma plot version 8.0. A value of p < 0.05 was considered as 
statistically significant.
Three  ml  reaction  mixture  consisted  of   
1.5 ml of 0.1 M sodium carbonate buffer, 
pH 10.2; 0.01 ml of 0.03 M EDTA, suit-
able  aliquot  of  enzyme  preparation  and 
water to make up the volume to 2.94 ml. 
The  reaction  was  started  by  addition  of 
0.06 ml of 0.015 M epinephrine. Change 
in absorbance was recorded for one minute 
at  15  sec  interval.  Control  lacking  the 
enzyme, was run simultaneously.
One  unit  of  the  enzyme  activity  has 
been  defined  to  cause  50%  inhibition 
of  epinephrine  auto-oxidation  by  1  ml 
enzyme.
Protein analysis. Protein was estimated 
by  the  method  of  Lowry  et  al.26  using 
Folin  phenol  reagent  with  bovine  serum 
albumin as standard.
The specific activity of the enzyme has 
been expressed as activity/mg protein.
Total  thiols.  Total  thiols  in  plasma 
were  measured  by  the  method  of  Hu.27 
In  final  volume  of  4.0  ml.  was  added 
0.05  ml  plasma;  0.6  ml  of  0.25  M  tris 
buffer containing 0.02 M EDTA, pH 8.2 
followed by addition of 0.04 ml of 0.01 M 
2,2-dithiobisnitrobenzoic acid (DTNB) in 
absolute methanol and 3.31 ml of absolute 
methanol.  The  tubes  were  capped  and 
color was developed for 15 min at room 
temperature. The tubes were then centri-
fuged at 3,000 xg for 20 min. Supernatant 
was  collected  and  absorbance  measured 
at 412 nm. Total thiol groups were calcu-
lated using molar extinction coefficient of 
13,600 at 412 nm.
Lipid peroxidation. Lipid peroxidation 
was monitored in terms of malondialde-
hyde (MDA) by the method of Ohkawa, 
Ohishi  and  Yagi28  using  thiobarbituric 
acid  (TBA)  reagent.  To  0.2  ml  plasma 
was added 0.2 ml of 8.1% [w/v] sodium 
dodecyl sulphate; 1.5 ml 20% [v/v] acetic 
acid, pH 3.5; 1.5 ml of 0.8% TBA and 
water to make up the volume to 4.0 ml. 
The tubes were heated in a water bath at 
95°C for one hour and cooled immediately 
under  running  tap  water. To  each  tube, 
1.0 ml chilled water and 5.0 ml of butanol and pyridine [15:1 
v/v] were added and the tubes vortexed and centrifuged at 800 xg 
for 20 min. The upper layer was aspirated out and color intensity 
measured at 532 nm. 1,1,3,3-tetra ethoxy propane (TEP) was used 
as the reference.
Ascorbic acid. Ascorbic acid was measured by the method of 
Omaye, Turnbull and Sauberlich.29 This method is based on the 
Figure 2. Plasma levels of total thiols in healthy subjects and patients.
Figure 3. Ascorbic Acid levels in plasma of healthy subjects and patients.Antioxidants status and MDA levels in head and neck cancer
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